Home/Pipeline/SLF™ AV Graft

SLF™ AV Graft

Hemodialysis Vascular Access

ApprovedActive

Key Facts

Indication
Hemodialysis Vascular Access
Phase
Approved
Status
Active
Company

About Vascular Flow Technologies

Vascular Flow Technologies is a specialized medical device contract development and manufacturing organization (CDMO) with a proprietary technology platform. Founded in 2007 and based in Dundee, Scotland, the company leverages its Spiral Laminar Flow (SLF™) technology to assist partners in developing and commercializing improved cardiovascular devices. It operates a three-pronged business model: licensing its SLF™ technology, providing end-to-end device development services, and offering contract manufacturing in a Class 7 cleanroom. A recent milestone includes FDA clearance for an SLF™-enabled AV graft for hemodialysis, indicating progression into commercial-stage activities.

View full company profile

Therapeutic Areas